Chemo Pharma Laboratories Limited (CHEMOPH.BO)
INR 124.0
(1.6%)
INR 124.0
(1.6%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 7.23 Million | -6.83 Million | -3.28 Million | -4.08 Million | 48.32 Million |
| Net Income | 16.43 Million | 731.97 Thousand | 3.64 Million | 3.1 Million | 4.15 Million |
| Depreciation & Amortization | 83 Thousand | 131.01 Thousand | 189.31 Thousand | 239.38 Thousand | 231.27 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 860 Thousand | -493.9 Thousand | 275.87 Thousand | -1.23 Million | 53.9 Million |
| Other non-cash items | -5.99 Million | -4.72 Million | -4.74 Million | -5.3 Million | -9.96 Million |
| Investing Cash Flow | -5.24 Million | 6.29 Million | 9.67 Million | -1.85 Million | 10.09 Million |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 131.91 Thousand |
| Other Investing Activities | -5.24 Million | -10.00 | 990.00 | -1.85 Million | 10.09 Million |
| Financing Cash Flow | -1.48 Million | -763.09 Thousand | -21.24 Million | 19.56 Million | - |
| Debt repayment | - | - | -21.24 Million | -19.56 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1.48 Million | -763.09 Thousand | -21.24 Million | 19.56 Million | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 860 Thousand | -493.9 Thousand | 217.04 Thousand | -1.25 Million | 53.9 Million |
| Cash at beginning of period | 5.55 Million | 6.85 Million | 21.71 Million | 8.08 Million | 29.66 Million |
| Cash at end of period | 6.05 Million | 5.55 Million | 6.85 Million | 21.71 Million | 88.08 Million |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 499 Thousand | -1.3 Million | -14.85 Million | 13.62 Million | 58.42 Million |
| Free Cash Flow | 7.23 Million | -6.83 Million | -3.28 Million | -4.08 Million | 48.32 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.46 Million | -2.91 Million | 16.43 Million | 6.76 Million | 4.39 Million | 3.76 Million |
| Depreciation & Amortization | - | - | 83 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 860 Thousand | - | - | - |
| Other non-cash items | -2.46 Million | 2.91 Million | -5.99 Million | -6.76 Million | -4.39 Million | -3.76 Million |
| Investing Cash Flow | - | - | -5.24 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -5.24 Million | - | - | - |
| Financing Cash Flow | - | - | -1.48 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1.48 Million | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 860 Thousand | - | - | - |
| Cash at beginning of period | - | - | 5.55 Million | - | - | - |
| Cash at end of period | - | - | 6.05 Million | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 499 Thousand | - | - | - |
| Free Cash Flow | - | - | 7.23 Million | - | - | - |
TUP
U
MALDF
BNVIF
5026
NNN1